GEHC GE Healthcare RESULTS: Q2, Q2 ADJ EPS $1.13 vs. EST $1.04, Q2 Net Income $561M, Q2 REV $5.300B vs. EST $5.264B, Q2 EPS $1.24, Ge Health
GEHC GE Healthcare RESULTS: Q2, Q2 ADJ EPS $1.13 vs. EST $1.04, Q2 Net Income $561M, Q2 REV $5.300B vs. EST $5.264B, Q2 EPS $1.24, Ge Healthcare Earnings Notes:, Reaffirms full-year 2026 guidance, Reaffirms full-year 2026 guidance, Are reviewing strategic options to maximize its long-term value, Do not expect material benefit to ADJ ebit margin* and ADJ EPS* from additional refunds for tariffs incurred in 2026., Benefits of refunds for tariffs incurred in 2026 are included in guidance for 2026 ADJ ebit margin and ADJ EPS
GEHC GE Healthcare RESULTS: Q2, Q2 ADJ EPS $1.13 vs.
EST $1.04, Q2 Net Income $561M, Q2 REV $5.300B vs.
EST $5.264B, Q2 EPS $1.24, Ge Healthcare Earnings Notes:, Reaffirms full-year 2026 guidance, Reaffirms full-year 2026 guidance, Are reviewing strategic options to maximize its long-term value, Do not expect material benefit to ADJ ebit margin* and ADJ EPS* from additional refunds for tariffs incurred in 2026., Benefits of refunds for tariffs incurred in 2026 are included in guidance for 2026 ADJ ebit margin and ADJ EPS